Elementis PLC
03 September 2007
3 September 2007
Elementis announces completion of sale of its Global Pigments Business
Elementis plc is pleased to announce that the sale of its Global Pigments
business was completed on 31 August 2007. The sale, announced on 11 May 2007,
was subject to regulatory approvals including a filing under the
Hart-Scott-Rodino Act in the United States. Clearance to complete was received
during August.
The proceeds from the sale (on a cash and debt free basis) were US$140 million
(£70 million) and will initially be used to pay down debt.
David Dutro, Chief Executive of Elementis, commented: 'The expeditious
completion of this transaction was one of our stated goals for the second half
of the year and leaves us well positioned to focus on growing our Specialty
Products business.'
Enquiries
Elementis plc Tel: +44 (0) 207 408 9300
David Dutro Chief Executive
Brian Taylorson Finance Director
Financial Dynamics Tel: +44 (0) 207 831 3113
Andrew Dowler
Greg Quine
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.